Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-1-4
pubmed:abstractText
To evaluate relationships between various body-size measures and irinotecan (CPT-11) clearance and metabolism in cancer patients, and to provide future dosing recommendations for this agent.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
81-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11773157-Adult, pubmed-meshheading:11773157-Aged, pubmed-meshheading:11773157-Antineoplastic Agents, Phytogenic, pubmed-meshheading:11773157-Body Constitution, pubmed-meshheading:11773157-Body Surface Area, pubmed-meshheading:11773157-Camptothecin, pubmed-meshheading:11773157-Colorectal Neoplasms, pubmed-meshheading:11773157-Dose-Response Relationship, Drug, pubmed-meshheading:11773157-Female, pubmed-meshheading:11773157-Humans, pubmed-meshheading:11773157-Infusions, Intravenous, pubmed-meshheading:11773157-Linear Models, pubmed-meshheading:11773157-Male, pubmed-meshheading:11773157-Metabolic Clearance Rate, pubmed-meshheading:11773157-Middle Aged, pubmed-meshheading:11773157-Multivariate Analysis, pubmed-meshheading:11773157-Netherlands, pubmed-meshheading:11773157-Retrospective Studies
pubmed:year
2002
pubmed:articleTitle
Impact of body-size measures on irinotecan clearance: alternative dosing recommendations.
pubmed:affiliation
Department of Medical Oncology, Rotterdam Cancer Institute (Daniel den Hoed Kliniek), 3008 AE Rotterdam, the Netherlands.
pubmed:publicationType
Journal Article